Retrospective Analysis of Treatment Results for Nasopharyngeal Carcinoma in Philippine Oncology Centre Corporation from 2002–2009

Yew Poh Chong, Salave Arnold, Cesar Benedict Mario


Objective: This study aimed to determine the treatment outcomes and late effects of radiotherapy for NPC patients treated in Philippine Oncology Centre Corporation (POCC). Materials and Methods: The patients with NPC referred for treatment at POCC from 2002-2009 were retrospectively analyzed. Treatment outcomes were 5 years overall survival (OS), disease free survival (DFS), cause-specific survival (CSS), loco-regional control (LRC) and radiotherapy-related late effects. The Kaplan-Meier method was used for survival analysis and differences in survival according to AJCC stage was compared using the log-rank test. Results: A total of 106 patients with newly diagnosed NPC were treated in POCC during this period. Late presentation was common, with 19.8% presenting with T3-4 disease, 88.7% with N1-3 disease and 73.5% with AJCC stage 3-4 disease. Radical RT was given to 96 patients with 23.6% having RT alone and 67.4% having CCRT. The stipulated OTT was 7 weeks and 72% managed to complete their RT within this time period. Neoadjuvant chemotherapy was given to 13.5% while adjuvant chemotherapy was administered to 17%. The 5 years OS was 51.5% with a median follow up of 56 months. The 5 years OS according to stage were 81.8% for stage I, 77.9% for stage II, 47.4% for stage III and 25.9% for stage IV. The 5 years overall CSS, DFS and LRC were 54.4%, 48.4% and 70.9%, respectively. RT related late effects were documented in 71.7%. The commonest was xerostomia (66.7%). Other documented late effects were hearing deficit (18.2%), visual deficit (4.2%), neck stiffness (4.2%), dysphagia (2.3%), cranial nerve palsy (2.4%), pneumonitis (0.9%) and hypothyroidism (1.3%). Conclusions: The 5 years OS and LRC in this study are low compared to the latest studies especially those utilizing IMRT. Implementation of IMRT for NPC treatment should be strongly encouraged.

Full Text:



Chao KSC, Deasy JO, Markman J, et al (2001). A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys, 49, 907-15.

Phua CE, Tan BS, Yong TK, et al (2011). Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Penang General Hospital from 2001-2005. Asian Pac J Cancer Prev, 12, 3197-200.

Baujat B, Bourhis J, Chan AT, et al (2006). Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phy, 64, 47-56.

Chan ATC, Gregoire V, Lefebvre, et al (2012). Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23, 83-5.

Ali H, Al-Sarraf M (1999). Nasopharyngeal cancer. Hematol Oncol Clin North Am, 13, 837-48.

Cox JD, Pajak TF, Marcial VA, et al (1992). Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313. Cancer, 69, 2744-8.

Hsu MM, Huang SC, Lynn TC, et al (1982). The survival of patients with nasopharyngeal carcinomas. Otolaryngol Head Neck Surg, 90, 289-95.

Langendijk JA, Leemans CR, Buter J, et al (2004). The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Onco, 22, 4604-12.

Kwong LW, Sham ST, Chua TT, et al (1997). The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 39, 703-10.

Lee AW, Poon YF, FOO KW, et al (1992). Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and pattern of failure. Int J Radiat Oncol Biol Phys, 23, 261-70.

Kam KM, Leung SF, Zee B, et al (2007). Prospective randomized study of Intensity-Modulated Radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol, 25, 4873-9.

Lee AWM, Law SCK, Foo W, et al (1993). Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Phys, 26, 773-82.

Malaysian Cancer Statistics-Data and Figure Peninsular Malaysia 2006. National Cancer Registry, Ministry of Health Malaysia.

Lin SJ, Pan JJ, Han L, et al (2009). Nasopharyngeal carcinoma treated with reduced volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys, 75, 1071-8.

Shu-Chen H (1980). Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radit Oncol Biol Phys, 6, 401-7.

Luo RX, Tang QX, Guo KP, et al (1994). Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinomaAn analysis of 1446 cases with squamous cell carcinoma grade 3. Int J Radiat Oncol Biol Phys, 30, 1107-9.

Lee N, Xia P, Quivey JM, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22.

Al-Sarraf M, Pajak TF, Cooper JS, et al (1990). Chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a Radiation Therapy Oncology Group study. J Clin Oncol, 8, 1342-51.

Phua CE, Tan BS, Tan AL, et al (2012). Intensity-modulated radiotherapy for nasopharyngeal carcinoma: Penang General Hospital experience. Asian Pac J Cancer Prev, 13, 3287-92.

Qin DX, Hu YH, Yan JH, et al (1998). Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer, 61, 1117-24.

Lin ZX, Li DR, Chen ZJ, et al (1999). What is the significance of nasal involvement in nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys, 45, 907-14.

Terence PF, Fernando LD, Roberto AL, et al (2003). Prognostic Factors and Outcome for Nasopharyngeal Carcinoma. Arch Otolaryngol Head Neck Surg, 129, 794-9.

Vikram B, Mishra UB, Strong EW, et al (1985). Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys, 11, 1455-9.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

eISSN: 2312-0398

Asia Press is a professional Science, Technology and Medicine publisher, who owns rapid publication, Peer-Reviewed, Open Access Journals. Asia Press aims to promote “knowledge sharing”. As you know, the main barrier for free “knowledge sharing” is the cost of publishing and transfer. In order to encourage scholars and scientists to the max, and devote whole power to realize the aim of “knowledge sharing” and the benefit of “all” mankind, Asia Press performs a permanent policy of no charge for publication and access, and always open its door for authors worldwide.

© 2013-2017 by the Asia Press. All rights reserved.